Supplementing chemotherapy with dazostinag activates dendritic cells in head and neck squamous cell carcinoma, implying enhanced immune response.
Figure S9. Dazostinag alone and combined with chemotherapy may activate dendritic cells.
No takes yet. Share an insight, caveat, or question.
Gregory et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: